Ulcers and gastritis

Endoscopy

Volumn 28, Issue 1, 1996, Pages 38-43

  Tytgat, G N J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

DUODENUM ULCER; ENDOSCOPIC BIOPSY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INSTRUMENT STERILIZATION; PRIORITY JOURNAL; REVIEW; STOMACH ULCER;

EID: 0030010328     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1005416     Document Type: Review

References (44)

1. The Eurogast Study Group: Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-1676.
2. Bamford KB, Bickley J, Collins JS, et al.: Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamilial infection. Gut 1993; 34: 1348-1350.
3. Vaira D, Miglioli M, Mule P, et al.: Prevalence of peptic ulcer in Helicobacter pylori-positive blood donors. Gut 1994; 35: 309-312.
4. + Helicobacter pylori strains. J Clin Microbiol 1995; 33: 1496-1500.
5. Kuipers EJ, Thijs JC, Festen HPM: The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 (suppl 2): 59-69.
6. Tytgat GNJ: Endoscopic transmission of Helicobacter pylori. Aliment Pharmacol Ther 1995; 9 (suppl 2): 105-110.
7. Roosendaal R, Kuipers EJ, Van den Brule AJ, et al.: Importance of the fiberoptic endoscope cleaning procedure for detection of Helicobacter pylon in gastric biopsy specimens by PCR. J Clin Micobiol 1994, 32: 1123-1126.
8. Fantry GT, Zheng OX, James SP: Conventional cleaning and disinfection techniques eliminate the risk of endoscopic transmission of Helicobacter pylori. Am J Gastroenterol 1995; 90: 227-232. This is a very important paper illustrating that meticulous cleaning and disinfection of endoscopic equipment fully eliminated the risk of endoscopic transmission of Helicobacter pylori. Without such precautions, transmission is possible, because heavy contamination of the endoscope and endoscopic equipment is possible after examining a patient with Helicobacter pylori infection.
9. Lin SK, Lambert JR, Schembri MA, et al.: Helicobacter pylori prevalence in endoscopy and medical staff. J Gastroenterol Hepatol 1994; 9: 319-324.
10. Chong J, Marshall BJ, Barkin JS, et al.: Occupational exposure to Helicobacter pylori for the endoscopy professional: a sera epidemiological study. Am J Gastroenterol 1994; 89: 1987-1992.
11. Pristautz H, Eherer A, Brezinschek R, et al.: Prevalence of Helicobacter pylon antibodies in the serum of gastroenterologists in Austria. Endoscopy 1994; 26: 690-696.
12. Maaroos HI, Kekki M, Vorobjova T, et al.: Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization: a long-term follow-up study of 25 patients. Scand J Gastroenterol 1994; 29: 532-536.
13. Lee A, Dixon MF, Danon SJ, et al.: Local acid production and Helicobacter pylon: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 461-465.
14. Genta RM, Graham DY: Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylon density and distribution. Gastrointest Endosc 1994; 40: 342-345.
15. Lagan RP, Walker MM, Misiewicz JJ, et al.: Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-16.
16. Solcia E, Villani L, Fiocca R, et al.: Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994; 29 (suppl 201): 28-34. This important, carefully performed study illustrates the worsening of gastric inflammation in the corpus area during acid-suppressive therapy. This phenomenon fits with the hypothesis that H. pylori can only flourish when the acid-secretory potential of the affected mucosa is rather low or suppressed. More luxurious growth of H. pylori appears to be responsible for aggravating the inflammatory changes.
17. Kuipers EJ, Klinkenberg-Knol EC, Havu N, et al.: Helicobacter pylori and development of atrophic gastritis during omeprazole maintenance therapy. Gastroenterology 1995; 108: A137. This is a landmark study, showing quite rapid progression of gastritis toward atrophy in H. pylori-mfected patients during non-stop omeprazole therapy. Apparently, such changes did not occur when the gastric mucosa was normal at the start. The logical consequence of these findings would be that it is mandatory to cure the infection and heal the mucosa is before embarking on long-term acid-suppressive therapy.
18. Sung JJ, Chung SC, Ling TK, et al.: One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori. Am J Gastroenterol 1994; 89: 199-202.
19. Seppälä K, Pikkarainen P, Sipponen P, et al.: Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Gut 1995; 36: 834-837.
20. NIH Consensus Conference: Helicobacier pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-69. In this landmark report of a consensus meeting of the National Institutes of Health in Bethesda, a plea is made to treat all H. pylori-associated peptic ulcer disease patients, both at primary diagnosis and during maintenance therapy, with acid-suppressive drugs, with a therapy aimed at curing the infection. This paper represents a major breakthrough in the overall therapeutic approach for patients with peptic ulcer disease.
21. Lindell G, Celebiogly F, Von-Holstein CS, et al.: On the natural history of peptic ulcer. Scand J Gastroenterol 1994; 29: 979-982.
22. Graham DY, Hepps KS, Ramirez FC, et al.: Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-942.
23. Labenz J, Borsch G: Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
24. Rokkas T, Karamesis A, Maurogeorgis A, et al.: Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
25. Jaspersen D, Koerner T, Schors W, et al.: Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41: 5-7.
26. Tytgat GNJ: Treatments that impact favorably upon the eradication of Helicobacier pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-368.
27. Bazzoli F, Zagari RM, Fossi n, et al.: Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-777.
28. De Boer WA, Driessen WMM, Poners HVPJ, et al.: Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89: 1993-1997.
29. Labenz J, Rühl GH, Bertrams J, et al.: Clinical course of duodenal ulcer disease one year after omeprazole plus amoxycillin or triple therapy plus ranitidine for cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6: 293-297.
30. Bayerdörffer E, Miehlke S, Mannes GE, et al.: Double-blind trial of omeprazole and amoxycillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108: 1412-1417.
31. De Boer WA, Driessen WMM, Jansz A, et al.: Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-820.
32. De Boer WA, Tytgat GNJ: The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995; 30: 401-407.
33. Borody W, Andrews P, Mancuso N, et al.: Helicobacter pylori reinfection rate in patients with cured duodenal ulcer. Am J Gastroenterol 1994; 89: 529-532.
34. Xiu HX, Windle HJ, Marshall DG, et al.: Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1995; 37: 30-34. This study again confirms some initial data from the Amsterdam study showing that cases with "apparently" recurrent infection with Helicobacter pylori appeared to be due to recrudescent disease, since the same organism was cultured as had been present before. This can readily be done with DNA typing. These investigators used the technique of randomly amplified polymorphic DNA fingerprinting.
35. McCarthy C, Patchett S, Collins RM, et al.: Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40: 114-119.
36. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-816. This well-performed study shows that immediate endoscopy is to be preferred over empirical therapy in chronic dyspepsia. This is a highly controversial area, as is illustrated by the fact that several editorial comments followed the publication of this paper. Since this study was carried out, serologic screening for H. pylori infection has become available, which may again change the approach to patients with dyspepsia.
37. Fennerty MB: Comment [on reference 36 above; editorial]. Gastrointest Endosc 1995; 41: 529-530.
38. Rabeneck L: Managing dyspepsia: is prompt endoscopy the way to go? [editorial]. Gastroenterology 1995; 108: 1324-1325.
39. Tham TC, McLaughlin N, Hughes DF, et al.: Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J 1994; 70: 809-812.
40. Mendall MA, Jazrawi RP, Marrero JM, et al.: Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995; 36: 330-333.
41. Axon ATR, Bell GD, Jones RH, et al.: Guidelines on appropriate indications for upper gastrointestinal endoscopy. Br Med J 1995, 310: 853-856.
42. Nozaki R, Fujiyoshi T, Tamura M, et al.: Evaluation of small-caliber transnasal panendoscopes for upper GI screening examination. Dig Endosc 1995; 7: 155-159.
43. Weil J, Colin-Jones D, Langman M, et al.: Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827-830.
44. Fishbein VA, Rosen AM, Lack EE, et al.: Diffuse hemorrhagic gastroenteropathy: report of a new entity. Gastroenterology 1994; 106: 500-505.